Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induction of Sustained Unresponsiveness to Peanuts Using High- and Low-dose Peanut Oral Immunotherapy - Evaluation of Efficacy and Safety

NCT05163574 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.

NCT NCT05163574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05163574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induction of Sustained Unresponsiveness to Peanuts Using High- and Low-dose Peanut Oral Immunotherapy - Evaluation of Efficacy and Safety
Lead sponsor
Medical University of Warsaw
Phase
Not applicable
Overall status
Unknown status
Start date
February 5, 2022
Completion date
June 30, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peanut allergy